真武汤联合TC方案治疗卵巢癌术后患者的近期临床效果观察

发布时间：2018-10-30 18:42

【摘要】：目的探讨真武汤联合TC方案治疗卵巢癌术后患者的近期临床效果。方法选取2008年1月到2014年1月于我院就诊的卵巢癌术后患者共80例,将患者采用随机分组方法分为两组,每组各40例。对照组患者给予单纯的TC化疗治疗,观察组在对照组基础之上,同时给予真武汤方案治疗,观察和比较两组患者术后康复效果和并发症发生率等方面的情况。结果观察组患者在接受上述治疗后,其中痊愈、好转以及显效人数分别为25例、10例5例,无效0例,治疗总有效率达到100.00%;对照组中患者痊愈21例,5例好转,显效2例,无效2例,治疗总有效率达95.00%。患者治疗效果对比有统计学意义,P0.05,治疗后,观察组患者中出现红肿1例,疼痛1例,术后并发症发生率为5%,而对照组中疼痛2例,感染1例以及红肿2例,并发症发生率为12.5%,组间比较具有统计学意义,P0.05。结论为了提高卵巢癌患者术后康复水平和治疗的总有效水平,可以在卵巢癌患者接受治疗时,给予患者真武汤联合TC方案治疗,以提高改善患者预后质量,具有积极的临床推广意义。
[Abstract]:Objective to investigate the short-term clinical effect of Zhenwu decoction combined with TC regimen in the treatment of ovarian cancer after operation. Methods from January 2008 to January 2014, 80 patients with ovarian cancer were randomly divided into two groups, 40 patients in each group. The patients in the control group were treated with simple TC chemotherapy, while the patients in the observation group were treated with Zhenwu decoction regimen on the basis of the control group. The effect of postoperative rehabilitation and the incidence of complications were observed and compared between the two groups. Results after receiving the above treatment, the patients in the observation group were cured, improved and markedly effective in 25 cases, 5 cases in 10 cases, and 0 cases in ineffectiveness respectively. The total effective rate of the treatment reached 100.00g. In the control group, 21 cases were cured, 5 cases were improved, 2 cases were markedly effective, 2 cases were ineffective, the total effective rate was 95.00%. After treatment, there were 1 case of red swelling, 1 case of pain, and 5 cases of postoperative complications in the observation group, while in the control group, there were 2 cases of pain, 1 case of infection and 2 cases of redness. The incidence of complications was 12.5. The difference between the two groups was statistically significant (P 0.05). Conclusion in order to improve the postoperative rehabilitation and total effective level of ovarian cancer patients, Zhenwu decoction combined with TC regimen can be given to patients with ovarian cancer to improve the quality of prognosis. It has positive clinical significance.
【作者单位】：泸州医学院附属中医院;贵阳医学院;
【分类号】：R737.31

【参考文献】